InvestorsHub Logo
Followers 1328
Posts 250069
Boards Moderated 52
Alias Born 12/07/2009

Re: None

Tuesday, 07/11/2023 1:40:37 PM

Tuesday, July 11, 2023 1:40:37 PM

Post# of 2794
$NBIO 's lead candidate, Pritumumab (PTB), is a human monoclonal Antibody (Mab) that is progressing to Phase 2 clinical trials for the treatment of Brain Cancer.

For further information please visit our website www.nascentbiotech.com
Bullish
Bullish

Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NBIO News